Development and validation of a sensitive liquid chromatography tandem mass spectrometry assay for the simultaneous determination of ten kinase inhibitors in human serum and plasma

A liquid chromatography tandem mass spectrometry method for the analysis of ten kinase inhibitors (afatinib, axitinib, bosutinib, cabozantinib, dabrafenib, lenvatinib, nilotinib, osimertinib, ruxolitinib, and trametinib) in human serum and plasma for the application in daily clinical routine has bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Aghai, Fatemeh, Zimmermann, Sebastian, Kurlbaum, Max, Jung, Pius, Pelzer, Theo, Klinker, Hartwig, Isberner, Nora, Scherf-Clavel, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644392/
https://www.ncbi.nlm.nih.gov/pubmed/33155133
http://dx.doi.org/10.1007/s00216-020-03031-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644392/
https://www.ncbi.nlm.nih.gov/pubmed/33155133
http://dx.doi.org/10.1007/s00216-020-03031-7

Ejemplares similares